Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
+1 212 318 2000
Europe, Middle East, & Africa
+44 20 7330 7500
+65 6212 1000
British drug maker GlaxoSmithKline PLC said Wednesday that Chief Financial Officer Julian Heslop will retire at the end of March 2011.
The company said Heslop will be replaced by Simon Dingemans, a managing director and partner at Goldman Sachs Inc. GlaxoSmithKline said Dingemans has spent more than 25 years in investment banking and most recently led Goldman's European M&A business.
Heslop became GlaxoSmithKline's CFO in April 2005. He joined Glaxo Wellcome in 1998. The company combined with SmithKline Beecham in 2000 to form GlaxoSmithKline.